AIM-HIGH Stopped: No Benefit of Niacin

Dr. Christopher Cannon provides his perspective on the news today that the NIH is stopping a clinical trial on combination cholesterol treatment.

Christopher P. Cannon, MD, FACC

Statements or opinions expressed in this program reflects the views of the contributors and do not reflect the official policy of the ACCF, unless otherwise noted.

Source: AIM-HIGH Stopped: No Benefit of Niacin